On Tuesday, the S&P/ASX 200 Index (ASX: XJO) was out of form and tumbled lower again. The benchmark index fell 0.8% to 6,980.3 points.

Will the market be able to bounce back from this on Wednesday? Here are five things to watch:

ASX 200 expected to rise

The Australian share market looks set to rise on Wednesday following a decent night of trade on Wall Street. According to the latest SPI futures, the ASX 200 is expected to open the day 29 points or 0.4% higher this morning. In late trade in the United States, the Dow Jones is up 0.35%, the S&P 500 is up 0.3%, and the Nasdaq is up 0.75%. Things were looking even better at one stage before US markets pared some of their gains.

Oil prices jump

Energy producers such as Beach Energy Ltd (ASX: BPT) and Santos Ltd (ASX: STO) could have a good day after oil prices surged higher. According to Bloomberg, the WTI crude oil price is up 4.7% to US$125.04 a barrel and the Brent crude oil price has risen 4.9% to US$129.96 a barrel. News that the US and UK are banning Russian oil imports has boosted prices.

Nickel price surges

Miners with exposure to nickel, such as IGO Ltd (ASX: IGO), will be on watch today after a crazy night for the metal. According to the Financial Times, the spot nickel price surged to a record US$100,000 a tonne in one of the biggest short squeezes in history. Chinese billionaire Xiang Guangda is believed to be nursing losses in the billions after he bet against the metal. The nickel price was trading at around US$21,000 a tonne at the start of the year.

Gold price continues to rise

Gold miners Evolution Mining Ltd (ASX: EVN) and Northern Star Resources Ltd (ASX: NST) could have a strong day after the gold price continued to push higher. According to CNBC, the spot gold price is up 2.6% to US$2,048.2 an ounce. This has been driven by increasing demand for the safe haven asset due to the war in Ukraine.

Platinum shares upgraded to hold rating

Platinum Asset Management Ltd (ASX: PTM) shares could have ended their slide and now be a hold according to the team at Bell Potter. This morning the broker upgraded the fund manager’s shares to a hold rating with a $1.90 price target. This follows the release of its latest funds under management update.

The post 5 things to watch on the ASX 200 on Wednesday appeared first on The Motley Fool Australia.

More reading

• Here are the top 10 ASX shares today
• How these 2 Aussie fund managers have delivered 30%+ gains in the past year
• Up 17% this month, why the IGO (ASX:IGO) share price can keep gaining: broker
• These 3 ASX 200 shares are topping the volume charts on Tuesday
• 15% yield! But are these ASX high-yield shares dividend traps?

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/VXNfH0P

Looking for growth shares to buy? Well, here’s some good news! Listed below are two growth shares that have recently been named as buys with material upside potential.

Here’s what you need to know about them:

Altium Limited (ASX: ALU)

The first ASX growth share to look at is Altium. It is an electronic design software provider behind the Altium 365 and Altium Designer platforms.

Altium also has a number of complementary businesses such as Nexus and Octopart which have large opportunities and are generating significant revenues.

All in all, this means Altium has a portfolio of businesses that have positioned it perfectly to profit from the increasing demand for electronic design software due to the rapidly growing Internet of Things (IoT) and AI markets.

Bell Potter is a fan of Altium and was pleased with its “strong” half year results last month. It currently has a buy rating and $38.75 price target on the company’s shares.

Pro Medicus Limited (ASX: PME)

Another ASX growth share that is highly rated is Pro Medicus. It provides industry-leading software that facilitates the clinical assessment of medical images.

The team at Morgans is positive on the company and was very impressed with its recent half year update. This was particularly the case with its margins, which surprised to the upside.

It commented: “While revenues were in-line with our forecasts, EBIT margins (~65%) was really the standout, with a 600bp improvement versus our expectation of a 100bps decline on the pcp, where we assumed the resumption of major marketing conferences and travel expenses would curb margin growth. We were wrong.”

Morgans also notes that the company’s sales pipeline continues to strengthen, which bodes well for its future growth and is expected to underpin further operating leverage over the long term.

In light of this positive outlook, it recently retained its add rating and lifted its price target on the company’s shares to $56.20.

The post 2 high quality ASX growth shares analysts believe have 20%+ upside appeared first on The Motley Fool Australia.

More reading

• Altium (ASX:ALU) share price hinges on this key detail, top brokers say
• Glitch! Why are ASX tech shares getting hammered on Monday?
• Why we just sold Zip and bought Pro Medicus (ASX:PME) shares: fundie
• 3 buy-rated ASX growth shares analysts are recommending
• 2 ASX healthcare shares analysts rate as buys

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns and has recommended Altium and Pro Medicus Ltd. The Motley Fool Australia owns and has recommended Pro Medicus Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/VUmeMip

A portfolio manager has shed light on reasons to hold selective ASX shares amid the COVID-19 reopening and rising interest rates.

The fundie is holding Aristocrat Leisure Limited (ASX: ALL), Corporate Travel Management (ASX: CTD), Cleanaway Waste Management Ltd (ASX: CWY), and Qube Holdings Ltd (ASX: QUB).

Let’s take a look at why this expert is interested in these shares.

Why are these ASX shares beneficial?

SG Hiscock High Conviction Fund portfolio manager Hamish Tadgell outlined why he favours certain “reopening trades” at this time. Speaking to the Australian Financial Review, Tadgell said:

We continue to favour selective reopening trades and higher cyclical exposure which not only stand to benefit as demand recovers from the pandemic but also as rates tighten.

Outlining his reasons for this outlook on specific shares, Tadgell said:

Aristocrat Leisure and Corporate Travel … have experienced COVID-19 headwinds, but [have] been able to emerge stronger through taking market share and actively participating in industry consolidation.

Aristocrat is an Australian gaming technology company operating in 90 countries with multiple product offerings including pokie machines and casino management systems.

Meantime, Corporate Travel Management is a travel company offering events, leisure, loyalty, and wholesale travel to the corporate sector.

Commenting on two other shares he would hold, Tadgell added:

Cleanaway and Qube Logistics are two other quality companies with market leadership, a strong competitive advantage, assets that [are] hard to replicate and should benefit as borders open and volumes in their respective sectors recover.

Cleanaway is a waste management company providing environmental solutions in Australia and the United Kingdom.

Meanwhile, Qube is a logistics company operating in 130 locations including Australia, New Zealand, Singapore, Malaysia, and Papua New Guinea.

The Aristocrat share price finished 1.65% higher on Tuesday, while Corporate Travel slid 2.48%. Cleanaway closed the session 0.37% in the green today and Qube dropped 1.99%.

Share price recap

Aristocrat shares have gained 6% in the past year, while Corporate Travel Management is 7% higher.

Cleanaway has had a solid past 12 months, climbing nearly 19% although Qube has dropped more than 1% over that time.

For perspective, the  S&P/ASX 200 Index (ASX: XJO) has returned 3.57% in the past year.

The post 4 ASX shares we’re holding for both reopening and higher interest rates: expert appeared first on The Motley Fool Australia.

More reading

• WAM boss urges cashed-up ASX 200 companies to buy, invest or pay dividends
• Brokers name 3 ASX shares to buy today
• ASX 200 (ASX:XJO) midday update: Corp Travel Management’s ACCC boost, Zip downgraded
• Corporate Travel Management (ASX:CTD) share price higher on ACCC Helloworld update
• 2 great ASX shares to buy in March 2022: experts

The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Corporate Travel Management Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/gKAcrOY

Today, the S&P/ASX 200 Index (ASX: XJO) broke below 7,000 points once again as miners and energy shares lost their gusto. At the end of the session, the benchmark index finished 0.83% lower at 6,980.3 points.

Despite concerns of a material and energy supply shortage, companies operating in these sectors took a moment on the sidelines today as investors cashed in on the recent strength. Meanwhile, supermarket giants and healthcare shares added some green to the boards on Tuesday.

However, the question is: which shares delivered the biggest returns to investors on the ASX today? Here are the top ten stocks that came through for investors:

Top 10 ASX shares countdown today

Looking at the top 200 listed companies, Meridian Energy Ltd (ASX: MEZ) was the biggest gainer today. Shares in the New Zealand renewable electricity generator jumped 6.43% after the company released a copy of its slides from a presentation to the New Zealand Shareholders’ Association. Find out more about Meridian Energy here.

The next biggest gaining ASX share today was Imugene Ltd (ASX: IMU). The clinical-stage immuno-oncology company pushed higher despite there being no new announcements. Shares in the company gained 4.44% while the broader market weakened. Uncover the latest Imugene details here.

Today’s top 10 biggest gains were made in these ASX shares:

ASX-listed company	Share price	Price change
Meridian Energy Ltd (ASX: MEZ)	$4.80	6.43%
Imugene Ltd (ASX: IMU)	$0.235	4.44%
Zimplats Holdings Ltd (ASX: ZIM)	$29.37	3.89%
Summerset Group Holdings Ltd (ASX: SNZ)	$11.40	3.64%
Johns Lyng Group Ltd (ASX: JLG)	$7.98	3.64%
Woolworths Group Ltd (ASX: WOW)	$35.74	3.36%
CSL Ltd (ASX: CSL)	$256.65	2.80%
Wisetech Global Ltd (ASX: WTC)	$45.36	2.39%
Resmed Inc (ASX: RMD)	$33.70	1.94%
Coles Group Ltd (ASX: COL)	$17.50	1.86%

Our top 10 ASX shares today countdown is a recurring end-of-day summary to ensure you know which companies were making big moves on the day. Check-in at Fool.com.au after the market has closed during weekdays to see which stocks make the countdown.

The post Here are the top 10 ASX shares today appeared first on The Motley Fool Australia.

More reading

• How these 2 Aussie fund managers have delivered 30%+ gains in the past year
• These 3 ASX 200 shares are topping the volume charts on Tuesday
• 15% yield! But are these ASX high-yield shares dividend traps?
• ASX 200 (ASX:XJO) midday update: CSL and St Barbara charge higher
• 5 things to watch on the ASX 200 on Tuesday

Motley Fool contributor Mitchell Lawler has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns and has recommended CSL Ltd. and WiseTech Global. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended ResMed. The Motley Fool Australia owns and has recommended COLESGROUP DEF SET and WiseTech Global. The Motley Fool Australia has recommended ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/5W4rlCx

Shares in AVZ Minerals Ltd (ASX:AVZ) tracked lower today and finished 7% in the red by the close of trade on Tuesday.

The AVZ share price walked lower today despite no market-sensitive information from the company or its constituents.

Although, the benchmark S&P/ASX 200 Index (ASX: XJO) also finished down 65 basis points alongside the S&P/ASX 300 Metals & Mining Index (ASX: XMM), itself trailing the market at a 3.37% loss today.

One important factor to consider is that AVZ was just added to the benchmark index on 4 March, meaning shares are now susceptible to buying and selling from large investment funds restricted to ASX 200 shares in their mandate.

With both major indices taking a hit today, it appears there was weakness across the board in Australian markets today.

What else could be at play?

Understandably, many investors might be confused as to why AVZ is faltering today as the price of lithium continues to set record highs.

The battery metal has climbed more than 29% in a month and is up more than 600% in the last single year. Recently, it surged again from November last year and has set continuous record highs to today.

Even more perplexing, is that when zooming out and scoping out a longer time frame, the AVZ share price and the price of lithium (and what the market expects to pay) track each other very closely.

The chart below shows AVZ versus the March 2022 lithium futures contract’s rolling return over the past 12 months, plus the corresponding changes.

However, over the past week or so, the relationship has soured and there appears to be more at play than just the correlation between the price of lithium and AVZ stock.

Stock markets around the world have taken a beating in the past few weeks amid the tension and conflict arising from the Russia-Ukraine situation in Europe.

In fact, across the board asset classes are absorbing losses and there isn’t much escape for investors in the form of a safe haven.

Raw commodities, such as gold, lithium and nickel (and not necessarily equities backing these) are just about the only asset group that is faring gains in 2022, with most other sectors and/or products down considerably.

Nickel spot basically doubled overnight amid supply fears from the conflict in Europe, for example.

It has soared 144% in the past 5 days while the iShares MSCI World Index Fund (NYSE: URTH), i.e. the ‘world stock market’ has dropped nearly 4%.

As seen on the chart below, benchmarks for all major stock indices around the world are crumbling in 2022.

Each of the London FTSE 100 Index (UKX), the S&P 500 Index (NYSE: SPX), Germany’s DAX Performance Index (GDAXI), the S&P/ASX 200 Index and Euro Stoxx 50 (SX5E) are down considerably this year to date and have diverged completely from the commodities sector.

Notably, each of these benchmarks is (or was, anyway) heavily weighted towards a tech bias.

However, the global commodities bucket has outstripped traditional equity markets and is soaring to new highs, as seen by Bloomberg Commodities Index (BCOM) in purple and the S&P/ASX 300 Metals & Mining performance above.

When looking at AVZ from a longer timeframe – the last 6 months to be exact – we see it has tracked the Australian mining basket closely and is trading above the benchmark index by a considerable amount.

As such, it appears the selloff in AVZ shares is a part of a wider selloff across the board in markets today. A homage to remaining diligent to a long-term perspective when investing.

AVZ share price snapshot

In the last 12 months, the AVZ share price has soared over 303% and another 4% this year to date. During the past month of trading, shares have eclipsed a gain of 6%.

The current levels that AVZ is trading at mark the highest prices in its history since first listing on the ASX back in 2007.

The post Lithium’s up 29%, but the AVZ Minerals (ASX:AVZ) share price is down. What gives? appeared first on The Motley Fool Australia.

More reading

• Why these 2 ASX mining shares are in the spotlight today
• These ASX 200 shares are being dumped out of the index and replaced with…
• How have ASX lithium stocks been faring this reporting season?
• ASX 200 tech shares take a hammering as Ukraine fears escalate
• Here’s why this ASX All Ordinaries lithium share is surging 13% today

Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/EgZBJl7

Today wasn’t a great day for most ASX shares. The All Ordinaries Index (ASX: XAO) ended up losing 0.93% over this Tuesday’s trading session. But that loss was eclipsed by the Race Oncology Ltd (ASX: RAC) share price.

Race shares ended up finishing at $2.30 a share, down a nasty 9.8% for the day. What’s worse, the company hit $2.27 during intra-day trading a new 52-week low for Race Oncology. That puts the company’s losses over 2022 so far at 36%, including 17.3% over the past 5 trading days. Its 12-month loss now stands at 38%.

So why did this company have such a lousy day of trading today?

Race to the bottom for Race Oncology share price

Well, unfortunately, it’s not entirely clear. There were no announcements or news out of the company to speak of. Nor have there been since a major update in January, which was an activities update for the December quarter. Back then, the company announced that its capital raising had been successful and oversubscribed at $3 a share. Race also reported a healthy cash position as well as a “preclinical discovery into heart protection during cancer treatment”.

That caused the Race share price to rise at the time. But investors appear to have forgotten all about those developments today.

So while it’s unclear exactly what spooked investors today, it could just be the nature of the company itself. As a small-cap ASX share with a market capitalisation of just over $400 million, Race is a company that could have been treated as a more speculative investment by some of its shareholders. As such, on a day like today when investors didn’t seem in the mood to take risks, Race shares might have just been the victim of some fear-provoked selling pressure.

Whatever the reasons for today’s sell off, Race shareholders will undoubtedly be hoping for better fortunes over the rest of the week.

The post Why did the Race Oncology (ASX:RAC) share price drop 10% today? appeared first on The Motley Fool Australia.

More reading

• Black gold! 3 ASX energy shares pumping new 52-week highs today
• Ups and downs: Why is the Cettire share price leaping 10% today?
• The Cettire (ASX:CTT) share price is plunging 14% today. What’s going on?
• Hazer (ASX:HZR) share price rockets 14% on low-carbon hydrogen project
• Selling out? Cettire (ASX:CTT) share price slumps amid founder selling rumours

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/kp0szt1

The BlueScope Steel Limited (ASX: BSL) share price share price has fallen more than 8% today, making it one of the worst performers in the S&P/ASX 200 Index (ASX: XJO).

Looking at the overall performance of the ASX, the ASX 200 fell around 0.8% today.

The steelmaker has actually seen its shares fall by 11% this year, so its fall today represented a majority of the decline that it has seen in 2022.

What’s going on with the BlueScope Steel share price?

There was no material news out from the company today.

Interestingly, steel prices have been rising in recent days amid the Russian invasion of Ukraine.

According to reporting by Bloomberg, several large steel producers in Ukraine have closed because of the war. It’s normally a top-five exporter of steel to the EU, so this could cause supplies to tighten further there. Russian steel producers are also facing difficulties to export.

Data from Kallanish Commodities shows that EU steel prices jumped 22% to 1,160 euros a tonne.

However, iron ore prices have also been increasing. Iron ore prices have reportedly reached six-month highs of US$156.

Broker thoughts

UBS has just released a note that acknowledged the increasing costs that BlueScope is facing, which is expected to hurt profitability in FY22 and FY23. But the broker still rates the business as a buy w9th a price target of $25.75 based on a slightly better outlook in the longer-term.

BlueScope share price snapshot and valuation

Based on UBS’ latest estimates, the BlueScope share price is now valued at 8x FY23’s estimated earnings.

The post BlueScope Steel (ASX:BSL) share price sinks 9% appeared first on The Motley Fool Australia.

More reading

• ASX 200 (ASX:XJO) midday update: CSL and St Barbara charge higher
• BlueScope (ASX:BSL) share price tumbles despite ‘best half-year’ ever
• How far off is BHP (ASX:BHP) from producing ‘green steel’?

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/pZqgwdN

Stand aside Warren Buffet, Carl Icahn, and Peter Lynch. The next generation of famous investors might be women. Today is International Women’s Day 2022, and we’re looking at the women steering funds dominating the ASX benchmark index.

This year’s theme is ‘Break the Bias’. And while the world of finance is often dominated by male voices, it has the potential to be a great equaliser.

The latest ASX Australia Investor Study – published in 2020 – found that of the nine million Australians who invest, 42% are women.

Additionally, women made up 45% of new investors during the COVID-19 pandemic, and 51% of Australians intending to invest.

Another study, conducted in the United States by Fidelity Investments, found 71% of women aged between 25 and 40 invest outside of retirement.

Now, there’s just one more statistic to add – women tend to be better investors than their male counterparts.

Fidelity Investments found female investors, on average, outperform their male counterparts by 0.4%.

Today, for International Women’s Day, let’s celebrate the female fund managers dominating against the ASX benchmark.

International Women’s Day: 3 female fundies bringing impressive returns

Mary Manning – Alphinity Global Equity Fund

As of 31 January 2022, Aphinity’s Global Fund – with Manning at the helm – has brought investors a 12-month return of 32.6%.

For comparison, the S&P/ASX 200 Index (ASX: XJO) gained 5.7% over the 12 months ended 31 January.

Manning is one of five portfolio managers for the Global Fund. She also manages Alphinity’s Global Sustainably Equity Fund.

Emma Fisher – Airlie Funds Management’s Australian Equity Fund

As portfolio manager for Airlie Funds Management’s Australian Equity Fund, Fisher provided investors a 12-month return of 19.3% as of 28 February.

Fisher has managed the $296.9 million fund since 2018, having started her career in equity research eight years earlier.

Catherine Allfrey – WaveStone Capital’s Dynamic Australian Equity Fund

As WaveStone Capital principal and portfolio manager, Allfrey provided Dynamic Australian Equity Fund investors a gross 12-month return of 17.1% as of 31 January.

Allfrey also oversees WaveStone Capital’s Australian Share Fund. It provided a 14.9% gross return in the same time frame – outperforming the S&P/ASX 300 Index (ASX: XKO) by 5.3%.

The post International Women’s Day: 3 female fundies delivering 15%+ gains in a year appeared first on The Motley Fool Australia.

More reading

• How these 2 Aussie fund managers have delivered 30%+ gains in the past year
• Leading brokers name 3 ASX shares to sell today
• Top broker says this ASX share will surge another 17% amid soaring gold prices
• 3 ASX retail shares slumping to 52-week lows today
• Up 17% this month, why the IGO (ASX:IGO) share price can keep gaining: broker

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/JnApx2c

The past year has certainly not been the easiest for ASX investors. The immense volatility that we’ve seen over 2022 thus far has put a dampener on the reasonably solid returns we saw for ASX shares over 2021. On current pricing, the S&P/ASX 200 Index (ASX: XJO) has given investors a return of approximately 3.1% over the past 12 months. That’s not terrible by any means. But it’s also a figure that isn’t going to light any fires. So to hear that not one, but two ASX fund managers have managed to give investors 30% gains over the past 12 months is certainly something we should be paying attention to.

According to a report in the Australian Financial Review (AFR), the Collins Street Value Fund and the Ausbil Global Resources Fund are two managed funds that have delivered exceptional returns to investors over the past 12 months.

How did they do it? Well, it was reportedly thanks to some well-timed positions in the resources and energy sectors. ASX resources and energy shares have been the talk of the ASX town over the past few weeks. This is especially been the case more recently as global geopolitical crises such as the war in Ukraine crimp supply chains.

We’ve seen oil, gas and coal, as well as gold and copper, take flight in recent weeks. Oil is now at highs we haven’t seen for the best part of a decade.

Oil is black gold for these 30% fund managers

According to the report, the Collins Street Value fund launched a “special situations strategy targeting offshore oil companies” last year. It loaded the boat on Beach Energy Ltd (ASX: BPT) in particular, buying near the company’s “2021 lows”.

The managing director and portfolio manager for Collins Street Value, Michael Goldberg, told the report that investors’ willingness to move away from fossil fuels like oil has “clouded the reality of strong demand and weak supply that have pushed oil, gas and coal prices higher over the past year”. Here’s some more of what he said:

Oil was going to strengthen regardless and now we’re seeing Russia, a major oil producer, triggering uncertainty about output… There’s a massive tailwind and investors who view what we are seeing as a top because of Ukraine are missing the picture of what will happen in the next few decades.

Ausbil Global Resources has also benefitted enormously from hooking the bandwagon to the energy sector. The report notes that the fund’s third-largest holding is the US energy giant Occidental Petroleum Corporation (NYSE: OXY). Occidental shares have rocketed by more than 150% since last October, and by 40% in the past month alone. Ausbil’s Luke Smith told the report that he believes we are entering a “commodities supercycle”.

As of January 31, the Ausbil Global Fund had returned 29.8% over the preceding 12 months. The Collins Street Value Fund has reportedly gained more than 30% since the second half of last year.

The post How these 2 Aussie fund managers have delivered 30%+ gains in the past year appeared first on The Motley Fool Australia.

More reading

• These 3 ASX 200 shares are topping the volume charts on Tuesday
• 15% yield! But are these ASX high-yield shares dividend traps?
• ASX 200 (ASX:XJO) midday update: CSL and St Barbara charge higher
• 5 things to watch on the ASX 200 on Tuesday
• Here are the top 10 ASX shares today

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/dlzQMS5

Yesterday we looked at three ASX shares brokers have given buy ratings to this week.

Unfortunately, not all shares are in favour with them right now. Three that have just been given sell ratings are listed below. Here’s why these brokers are bearish on these ASX shares:

ASX Ltd (ASX: ASX)

According to a note out of Morgan Stanley, its analysts have retained their underweight rating and $73.70 price target on this stock exchange operator’s shares. This follows the release of the company’s monthly activity report, which reveals that futures volumes are still down materially over the prior corresponding period. In addition, the broker sees risks with the CEO leaving during the CHESS replacement. The ASX share price ended the day at $79.39 on Tuesday.

Blackmores Limited (ASX: BKL)

A note out of Goldman Sachs reveals that its analysts have downgraded this health supplements company’s shares to a sell rating with a $75.20 price target. Goldman was pleased with Blackmores’ performance during the first half but has concerns over its profit outlook. This is due to the company spending heavily to rebuild its brand in existing markets and launch into new markets. The Blackmores share price has now tumbled below this price target and was fetching $74.34 at Tuesday’s close.

Magellan Financial Group Ltd (ASX: MFG)

Analysts at UBS have retained their sell rating and cut their price target on this struggling fund manager’s shares to $13.50. According to the note, the broker believes that Magellan’s shares could still fall further due to fund outflow risks. This is particularly the case for its infrastructure funds, which the broker sees as an emerging risk. This follows a recent underperformance from this side of the business. The Magellan share price was trading at $14.22 on Tuesday afternoon.

The post Leading brokers name 3 ASX shares to sell today appeared first on The Motley Fool Australia.

More reading

• 15% yield! But are these ASX high-yield shares dividend traps?
• Down 31% this year: Top broker tips more pain for Magellan (ASX:MFG) share price
• ASX 200 (ASX:XJO) midday update: CSL and St Barbara charge higher
• Why this broker just downgraded Blackmores (ASX:BKL) shares to a sell rating
• 5 things to watch on the ASX 200 on Monday

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Blackmores Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/nzGVTW7